FDA grants Breakthrough Device Designation to ECG platform
DANVILLE - Tempus, a leader in artificial intelligence and precision medicine, announced the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Des…
DANVILLE - Tempus, a leader in artificial intelligence and precision medicine, announced the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Des…